Difference between revisions of "Turner JH, et al. Cancer Biother. Radiopharm. (2003) cited as Ref 550 in DOI: 10.1038/s41392-020-0110-5 (Q9813)"

From Wikibase.slis.ua.edu
Jump to navigation Jump to search
(‎Created a new Item: #quickstatements; #temporary_batch_1589975872009)
 
(‎Created claim: Fifth Author string (P153): Leahy MF, #quickstatements; #temporary_batch_1590155508986)
 
(12 intermediate revisions by the same user not shown)
Property / First Author string
 +
Turner JH
Property / First Author string: Turner JH / rank
 +
Normal rank
Property / Second Author string
 +
Martindale AA
Property / Second Author string: Martindale AA / rank
 +
Normal rank
Property / Third Author string
 +
Boucek J
Property / Third Author string: Boucek J / rank
 +
Normal rank
Property / DOI Identifier
 +
Property / DOI Identifier: 10.1089/108497803322287583 / rank
 +
Normal rank
Property / PubMed ID
 +
Property / PubMed ID: 14503945 / rank
 +
Normal rank
Property / Publication Date
 +
2003
Timestamp+2003-01-01T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 year
Before0
After0
Property / Publication Date: 2003 / rank
 +
Normal rank
Property / Published In Name String
 +
Cancer Biother. Radiopharm.
Property / Published In Name String: Cancer Biother. Radiopharm. / rank
 +
Normal rank
Property / Volume
 +
18
Property / Volume: 18 / rank
 +
Normal rank
Property / title
 +
131I-anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma: a phase II clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital (English)
Property / title: 131I-anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma: a phase II clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital (English) / rank
 +
Normal rank
Property / Page(s)
 +
513-524
Property / Page(s): 513-524 / rank
 +
Normal rank
Property / Fourth Author string
 +
Claringbold PG
Property / Fourth Author string: Claringbold PG / rank
 +
Normal rank
Property / Fifth Author string
 +
Leahy MF
Property / Fifth Author string: Leahy MF / rank
 +
Normal rank
links / sliswiki / namelinks / sliswiki / name
 +

Latest revision as of 13:52, 22 May 2020

Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language Label Description Also known as
English
Turner JH, et al. Cancer Biother. Radiopharm. (2003) cited as Ref 550 in DOI: 10.1038/s41392-020-0110-5
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8

    Statements

    Turner JH
    0 references
    Martindale AA
    0 references
    Boucek J
    0 references
    0 references
    2003
    0 references
    Cancer Biother. Radiopharm.
    0 references
    18
    0 references
    131I-anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma: a phase II clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital (English)
    0 references
    513-524
    0 references
    Claringbold PG
    0 references
    Leahy MF
    0 references